Yahoo
OTC Markets OTCQB - Delayed Quote USD

MustGrow Biologics Corp. (MGROF)

0.2770 +0.0140 (+5.32%)
As of October 29 at 4:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for MGROF
  • Previous Close 0.2630
  • Open 0.2542
  • Bid 0.2556 x 1500000
  • Ask 0.2822 x 2000000
  • Day's Range 0.2542 - 0.2630
  • 52 Week Range 0.2200 - 0.6760
  • Volume 4,500
  • Avg. Volume 3,887
  • Market Cap (intraday) 19.501M
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date Sep 2, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. Additionally, the company offers biological and regenerative agriculture solutions to support sustainable farming. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

mustgrow.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MGROF
41.81%
S&P/TSX Composite index (^GSPTSE)
11.46%

1-Year Return

MGROF
42.89%
S&P/TSX Composite index (^GSPTSE)
17.69%

3-Year Return

MGROF
63.26%
S&P/TSX Composite index (^GSPTSE)
88.35%

5-Year Return

MGROF
91.72%
S&P/TSX Composite index (^GSPTSE)
68.83%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 866.3k
Earnings -2.1M
Profit Margin -242.29%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-2M
0
2M
-300.0%
-250.0%
-200.0%
-150.0%
-100.0%
-50.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -58.53%

  • Return on Assets (ttm)

    -41.99%

  • Return on Equity (ttm)

    -222.54%

  • Revenue (ttm)

    9.51M

  • Net Income Avi to Common (ttm)

    -5.41M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.37M

  • Total Debt/Equity (mrq)

    10.21%

  • Levered Free Cash Flow (ttm)

    -2.08M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: